BioProcess International™ Conference & Exhibition

語言選擇

Did You Know?

North Carolina has the nation's third largest biotech industry for four years in a row, according to Ernst & Youngs 2007 global industry survey, Beyond Borders.
More than 50 companies manufacturing biologics, pharmaceuticals and diagnostics already call North Carolina home. These companies -- Biogen Idec, GlaxoSmithKline, Novozymes, Pfizer Animal Health, Talecris, and Wyeth -- operate some of the largest or most unique facilities of their kind.

BioProcess International™(BPI)會議及展示會成為生物醫藥品業界中最重要的會議。會期中除了高質量之演講，備受注目之議題、以及各種交流活動之外，尚包括了因應生物醫藥品業界需求之各種服務、機器、材料等。此外，參加BPI將有機會與這個領域中重要的人物直接進行會談。

網羅了從高層次戰略到實際案例學習等各種主題，BPI議程深入探討影響生物醫藥品業界之法令規範、技術、市場等各種主題。此外，亦預定安排因應正在從事單株抗體(mAb)、基因改造蛋白質、疫苗等生物製劑開發企業(大企業及中小企業)所需之演講及討論會。

網羅4大專題

製造效率與供應鏈之安全

邀請演講

Reinventing Biologics Pharmaceutical Development and Marketed Product Support Paul F. McKenzie Vice President, BIO Pharmaceutical Development and Marketed Product Support, Centocor R&D	ObamaCare: Stimulus Spending, System Reform and Market Change J.D. Kleinke Medical Economist and Author, Oxymorons: The Myth of a U.S. Health Care System	Future Trends in Biopharmaceutical Operations and Facilities Johannes Roebers, Ph.D. Senior Vice President, Head of Biologic Strategy, Planning & Operations, Elan Pharma International Limited, Ireland
Operational Excellence: The Opportunity in the Life Sciences Industry G.K. Raju, Ph.D. Executive Director, Manufacturing Initiatives, MIT Center for Biomedical Innovations	Integrating New Technologies in Upstream and Downstream Processing Konstantin Konstantinov, Ph.D. Vice President, Technology Development, Genzyme Corp.	In Pursuit of Quality: Continual Improvement, Innovation, and Regulatory Oversight Ali M. Afnán, Ph.D. Senior Staff Fellow, OPS, CDER, US FDA